GENE ONLINE|News &
Opinion
Blog

2021-07-19| Asia-Pacific

CYTENA Launches the Next-Generation Microbioreactor to Revolutionize Cell Culture

by Tyler Chen
Share To

CYTENA Bioprocess Solutions, a CELLINK company, launches S.NEST, a high throughput microbioreactor with a monitoring system that maximizes cell growth, reduces workflow time, and turns data into valuable insights.

Cell culture plays a critical role in drug discovery, selection, and biologics manufacturing. CYTENA emphasized that “S.NEST revolutionizes the way to do cell cultures with its unique technology to increase efficiency and productivity for biologics production, drug screening, and functional genomics studies.”

With the patented reciprocating mixing technology, S.NEST enables cells to grow in suspension cultures with optimal growth space and oxygen supply, releasing the lab from weeks of work for cell upscaling and expansion. 

Its incubation chambers have individual environmental settings and are compatible with four 96-well or 24-well culture plates, demonstrating high cell cultivation. What’s more, the camera module in the microbioreactor provides real-time pH and dissolved oxygen monitoring during cell growth. Besides, the software embedded in the system is able to transform monitored data into research insights, maximizing efficiency and value.

S.NEST™ microbioreactor

The next-generation microbioreactor is an important innovation for cell line development, and it certainly has huge potential in cell culture research. The bioreactor has been testified by worldwide users that it can increase cell growth, delivering better results. In addition, with the real-time monitoring system, S.NEST becomes the next-generation microbioreactor that provides valuable insights to boost cell line development. From now on, S.NEST will continue to upgrade and provide laboratories with highly efficient cell culture breakthroughs.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
CYTENA BPS and Leadgene Bio to Level Up Taiwan’s Protein Drugs Production
2022-06-05
CYTENA Bioprocess Solutions Closes $5M Funding to Develop Automatic High-throughput Screening Platform for Pharmaceuticals
2021-10-05
Cytena Bioprocess Solutions Closes Pre-A series Funding, Accelerates Development in Microbioreactors
2020-12-29
LATEST
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
Degrader-Antibody Conjugates (DACs): Targeted Degradation for Therapeutics
2024-02-19
EVENT
Scroll to Top